Put Options

18 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $297,739 - $378,313
1,300 Added 12.75%
11,500 $14,000
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $448,920 - $506,300
-2,000 Reduced 16.39%
10,200 $74,000
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $1.41 Million - $1.57 Million
-6,100 Reduced 33.33%
12,200 $64,000
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $701,664 - $776,224
-3,200 Reduced 14.88%
18,300 $85,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $1.01 Million - $1.16 Million
5,100 Added 31.1%
21,500 $160,000
Q3 2021

Nov 10, 2021

SELL
$212.27 - $248.7 $212,270 - $248,700
-1,000 Reduced 5.75%
16,400 $276,000
Q2 2021

Aug 11, 2021

BUY
$233.58 - $259.14 $1.12 Million - $1.24 Million
4,800 Added 38.1%
17,400 $121,000
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $110,955 - $129,300
-500 Reduced 3.82%
12,600 $107,000
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $389,484 - $463,806
-1,800 Reduced 12.08%
13,100 $100,000
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $797,810 - $887,230
3,400 Added 29.57%
14,900 $32,000
Q2 2020

Aug 10, 2020

SELL
$197.81 - $242.74 $652,773 - $801,042
-3,300 Reduced 22.3%
11,500 $38,000
Q1 2020

May 08, 2020

SELL
$182.24 - $241.7 $947,648 - $1.26 Million
-5,200 Reduced 26.0%
14,800 $152,000
Q4 2019

Feb 11, 2020

BUY
$189.21 - $243.2 $1.53 Million - $1.97 Million
8,100 Added 68.07%
20,000 $7,000
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $1.81 Million - $2.17 Million
-10,400 Reduced 46.64%
11,900 $34,000
Q1 2019

May 10, 2019

BUY
$180.87 - $203.88 $4.03 Million - $4.55 Million
22,300 New
22,300 $52,000
Q1 2018

May 11, 2018

SELL
$169.43 - $198.0 $2.1 Million - $2.46 Million
-12,400 Closed
0 $0
Q4 2017

Feb 09, 2018

SELL
$168.79 - $188.59 $354,459 - $396,039
-2,100 Reduced 14.48%
12,400 $20,000
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $2.43 Million - $2.77 Million
14,500
14,500 $16,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.